{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T10:24:30Z","timestamp":1790936670387,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Centre National de la Recherche Scientifique and Bordeaux 2 University"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.ejphar.2012.05.022","type":"journal-article","created":{"date-parts":[[2012,5,27]],"date-time":"2012-05-27T08:47:03Z","timestamp":1338108423000},"page":"8-16","source":"Crossref","is-referenced-by-count":8,"title":["Diverse effects of 5-HT2C receptor blocking agents on c-Fos expression in the rat basal ganglia"],"prefix":"10.1016","volume":"689","author":[{"given":"Nabila","family":"Kadiri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9lanie","family":"Lagi\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Le Moine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J","family":"Millan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"De Deurwaerd\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Navailles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2012.05.022_bib1","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/syn.20109","article-title":"Modulation of dopamine release by striatal 5-HT2C receptors","volume":"55","author":"Alex","year":"2005","journal-title":"Synapse"},{"key":"10.1016\/j.ejphar.2012.05.022_bib2","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/0166-2236(90)90107-L","article-title":"Functional architecture of basal ganglia circuits: neural substrates of parallel processing","volume":"13","author":"Alexander","year":"1990","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.ejphar.2012.05.022_bib3","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.0953-816X.2003.03125.x","article-title":"Turning behaviour induced by stimulation of the 5-HT receptors in the subthalamic nucleus","volume":"19","author":"Belforte","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.ejphar.2012.05.022_bib4","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1124\/jpet.106.104448","article-title":"Differential effects of 5-methyl-1-[[2-[(2-methyl-3-pyridyl)oxyl]-5-pyridyl]carbamoyl]-6-trifluoromethylindone (SB 243213) on 5-hydroxytryptamine(2C) receptor-mediated responses","volume":"319","author":"Berg","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2012.05.022_bib5","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.neuroscience.2010.04.061","article-title":"Stimulation of serotonin2C receptors elicits abnormal oral movements by acting on pathways other than the sensorimotor one in the rat basal ganglia","volume":"169","author":"Beyeler","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2012.05.022_bib6","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s00213-002-1247-3","article-title":"Local injections of the 5-hydroxytryptamine antagonist mianserin into substantia nigra pars reticulata block tremulous jaw movements in rats: studies with a putative model of Parkinsonian tremor","volume":"165","author":"Carlson","year":"2003","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ejphar.2012.05.022_bib7","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1124\/mol.107.041574","article-title":"Inverse agonist and neutral antagonist actions of antidepressants at recombinant and native 5-hydroxytryptamine2C receptors: differential modulation of cell surface expression and signal transduction","volume":"73","author":"Chanrion","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2012.05.022_bib8","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0028-3908(99)00086-6","article-title":"Immunohistochemical localisation of the 5-HT2C receptor protein in the rat CNS","volume":"39","author":"Clemett","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2012.05.022_bib9","doi-asserted-by":"crossref","first-page":"5170","DOI":"10.1523\/JNEUROSCI.20-13-05170.2000","article-title":"Nigrostriatal lesions alter orofacial dyskinesia and c-fos expression induced by the serotonin agonist 1-(m-cholophenyl)piperazine in adult rats","volume":"20","author":"De Deurwaerd\u00e8re","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2012.05.022_bib10","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.neulet.2009.12.006","article-title":"Selective blockade of serotonin2C receptor enhances Fos expression specifically in the striatum and the subthalamic nucleus within the basal ganglia","volume":"469","author":"De Deurwaerd\u00e8re","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2012.05.022_bib11","series-title":"The Pathophysiology of Central 5-HT2C Receptors","article-title":"Physiological and pathophysiological aspects of 5-HT2C receptors in basal ganglia","author":"De Deurwaerd\u00e8re","year":"2011"},{"key":"10.1016\/j.ejphar.2012.05.022_bib12","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1523\/JNEUROSCI.0112-04.2004","article-title":"Constitutive activity of the serotonin2C receptor inhibits in vivo dopamine release in the rat striatum and nucleus accumbens","volume":"24","author":"De Deurwaerd\u00e8re","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2012.05.022_bib13","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00213-008-1177-9","article-title":"S32006, a novel 5-HT2C receptor antagonist displaying broad-based antidepressant and anxiolytic properties in rodent models","volume":"199","author":"Dekeyne","year":"2008","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ejphar.2012.05.022_bib14","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00213-008-1259-8","article-title":"Discriminative stimulus properties of the atypical antidepressant, mirtazapine, in rats: a pharmacological characterization","volume":"203","author":"Dekeyne","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ejphar.2012.05.022_bib15","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.2174\/092986706778521805","article-title":"Serotonin involvement in the basal ganglia pathophysiology: could the 5-HT2C receptor be a new target for therapeutic strategies?","volume":"13","author":"Di Giovanni","year":"2006","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejphar.2012.05.022_bib16","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0079-6123(08)00921-7","article-title":"Serotonin modulation of the basal ganglia circuitry: therapeutic implication for Parkinson's disease and other disorders","volume":"172","author":"Di Matteo","year":"2008","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.ejphar.2012.05.022_bib17","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/(SICI)1096-9861(19970728)384:2<233::AID-CNE5>3.0.CO;2-2","article-title":"Pattern of expression of the Serotonin2C receptor messenger RNA in the basal ganglia of adults rats.","volume":"384","author":"Eberle-Wang","year":"1997","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.ejphar.2012.05.022_bib18","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.neuropharm.2009.05.011","article-title":"Characterizing the effects of 5-HT(2C) receptor ligands on motor activity and feeding behaviour in 5-HT(2C) receptor knockout mice","volume":"57","author":"Fletcher","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2012.05.022_bib19","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1006\/exnr.1998.6792","article-title":"Behavioral effects of 5-HT2C receptor antagonism in the substantia nigra zona reticulata of the 6-hydroxydopamine-lesioned rat model of Parkinson's disease","volume":"151","author":"Fox","year":"1998","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ejphar.2012.05.022_bib20","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s00228-007-0450-x","article-title":"Further evidence for the association between 5-HT2C receptor gene polymorphisms and extrapyramidal side effects in male schizophrenic patients","volume":"64","author":"Gunes","year":"2008","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2012.05.022_bib21","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0031-6997(25)06819-X","article-title":"Induction of immediate-early genes and the control of neurotransmitter-regulated gene expression within the nervous system.","volume":"47","author":"Hughes","year":"1995","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejphar.2012.05.022_bib22","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/j.neuroscience.2006.11.004","article-title":"Selective activation of 5-HT2C receptors stimulates GABA-ergic function in the rat substantia nigra pars reticulata: a combined in vivo electrophysiological and neurochemical study","volume":"144","author":"Invernizzi","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2012.05.022_bib23","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0006-8993(98)00082-1","article-title":"The 5-HT1A and 5-HT2A\/2C receptor antagonists WAY-100635 and ritanserin do not attenuate D-fenfluramine-induced fos expression in the brain","volume":"791","author":"Javed","year":"1998","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2012.05.022_bib24","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1476-5381.1996.tb15208.x","article-title":"In vitro and in vivo profile of SB 206553, a potent 5-HT2C\/5-HT2B receptor antagonist with an anxiolytic-like properties.","volume":"117","author":"Kennett","year":"1996","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2012.05.022_bib25","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/BF03033481","article-title":"Modeling tardive dyskinesia: predictive 5-HT2C receptor antagonist treatment","volume":"11","author":"Kostrzewa","year":"2007","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.ejphar.2012.05.022_bib26","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0165-6147(93)90048-O","article-title":"Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins","volume":"14","author":"Lefkowitz","year":"1993","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2012.05.022_bib27","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2174\/1568007043482598","article-title":"5-HT2 receptors","volume":"3","author":"Leysen","year":"2004","journal-title":"Curr. Drug Targets CNS Neurol. Disord."},{"key":"10.1016\/j.ejphar.2012.05.022_bib28","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/0024-3205(96)00423-7","article-title":"Receptor subtype and density determine the coupling repertoire of the 5-HT2 receptor subfamily","volume":"59","author":"Lucaites","year":"1996","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2012.05.022_bib29","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0893-133X(98)00087-6","article-title":"Effects of the 5-HT2C\/2B antagonist SB 206553 on hyperactivity induced by cocaine","volume":"20","author":"McCreary","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2012.05.022_bib30","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1124\/mol.62.6.1339","article-title":"Phospholipase D activation by endogenous 5-hydroxytryptamine 2C receptors is mediated by G\u03b113 and pertussis toxin-sensitive G\u03b2\u03b3 subunits","volume":"62","author":"McGrew","year":"2002","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2012.05.022_bib31","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0091-3057(00)00476-7","article-title":"Increased m-CPP induced dyskinesia after lesions of serotonergic neurons","volume":"68","author":"Mehta","year":"2001","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2012.05.022_bib32","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2515\/therapie:2005065","article-title":"Serotonin 5-HT2C receptors as a target for the treatment of depressive and anxious states: focus on novel therapeutic strategies","volume":"60","author":"Millan","year":"2005","journal-title":"Th\u00e9rapie"},{"key":"10.1016\/j.ejphar.2012.05.022_bib33","first-page":"1","article-title":"The melatonergic agonist and clinically active antidepressant, agomelatine, is a neutral antagonist at 5-HT2C receptors","volume":"15","author":"Millan","year":"2010","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.ejphar.2012.05.022_bib34","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S0306-4522(96)00452-6","article-title":"Quantitative and morphometric data indicate precise cellular interactions between serotonin terminals and postsynaptic targets in rat substantia nigra","volume":"76","author":"Moukhles","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2012.05.022_bib35","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.conb.2008.11.001","article-title":"Seven problems on the basal ganglia","volume":"18","author":"Nambu","year":"2008","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.ejphar.2012.05.022_bib36","series-title":"The Pathophysiology of Central 5-HT2C Receptors","article-title":"The constitutive activity of 5-HT2C receptors as an additional modality of interaction of the serotonergic system in motor control","author":"Navailles","year":"2011"},{"key":"10.1016\/j.ejphar.2012.05.022_bib37","doi-asserted-by":"crossref","unstructured":"Navailles, S., Lagi\u00e8re, M., Roumegous, A., Polito, M., Ben Boujema, M., Cador, M., Dunlop, J., Chesselet, M.F., Millan, M.J., De Deurwaerd\u00e8re, P. Serotonin2C ligands exhibiting full negative and positive intrinsic activity elicit purposeless oral movements in rats: distinct effects of agonists and inverse agonists in a rat model of Parkinson's disease. Int. J. Neuropsychopharmacol., http:\/\/dx.doi.org\/10.1017\/S1461145712000417, in press.","DOI":"10.1017\/S1461145712000417"},{"key":"10.1016\/j.ejphar.2012.05.022_bib38","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1111\/j.1471-4159.2006.04188.x","article-title":"Region-dependent regulation of mesoaccumbens dopamine neurons in vivo by the constitutive activity of central serotonin2C receptors","volume":"99","author":"Navailles","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2012.05.022_bib39","doi-asserted-by":"crossref","first-page":"9472","DOI":"10.1074\/jbc.274.14.9472","article-title":"RNA editing of the human serotonin 5-hydroxytryptamine 2C receptor silences constitutive activity","volume":"274","author":"Niswender","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2012.05.022_bib40","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1021\/jm00001a007","article-title":"(+)-cis-4,5,7a,8,9,10,11,11a-octahydro-7H-10-methylindolo[1,7-bc][2,6]-naphthyridine: a 5-HT2C\/2B receptor antagonist with low 5-HT2A receptor affinity","volume":"38","author":"Nozulak","year":"1995","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2012.05.022_bib41","series-title":"The rat brain in stereotaxic coordinates","author":"Paxinos","year":"1986"},{"key":"10.1016\/j.ejphar.2012.05.022_bib42","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0022-3565(24)29304-6","article-title":"Inverse agonist actions of typical and atypical antipsychotic drugs at the human 5-hydroxytryptamine2C receptor","volume":"299","author":"Rauser","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2012.05.022_bib43","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1038\/sj.npp.1301636","article-title":"Opposing roles for 5-HT2A and 5-HT2C receptors in the nucleus accumbens on inhibitory response control in the 5-choice serial reaction time task","volume":"33","author":"Robinson","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2012.05.022_bib44","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1007\/s002109900181","article-title":"In vivo electrophysiological examination of 5-HT2 responses in 5-HT2C receptor mutant mice.","volume":"361","author":"Rueter","year":"2000","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.ejphar.2012.05.022_bib45","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00213-010-1928-2","article-title":"The role of serotonin-2 (5-HT2) and dopamine receptors in the behavioral actions of the 5-HT2A\/2C agonist, DOI, and putative 5-HT2C inverse agonist, SR46349B","volume":"213","author":"Scarlota","year":"2011","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ejphar.2012.05.022_bib46","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0306-4522(97)00179-6","article-title":"Effect of electrical stimulation of the cerebral cortex on the expression of the Fos protein in the basal ganglia","volume":"81","author":"Sgambato","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2012.05.022_bib47","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/374542a0","article-title":"Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors","volume":"374","author":"Tecott","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2012.05.022_bib48","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0006-8993(95)00544-Z","article-title":"Acute administration of typical and atypical antipsychotic drugs induces distinctive patterns of Fos expression in the rat forebrain","volume":"688","author":"Wan","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2012.05.022_bib49","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s00213-004-1884-9","article-title":"5-HT2A and 5-HT2C receptor antagonists have opposing effects on a measure of impulsivity: interactions with global 5-HT depletion","volume":"176","author":"Winstanley","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ejphar.2012.05.022_bib50","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0028-3908(01)00054-5","article-title":"SB-243213: a selective 5-HT2C receptor inverse agonist with improved anxiolytic profile: lack of tolerance and withdrawal anxiety","volume":"41","author":"Wood","year":"2001","journal-title":"Neuropharmacology"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299912004657?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299912004657?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T22:39:55Z","timestamp":1743201595000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299912004657"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":50,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S0014299912004657"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2012.05.022","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}